|
IGC IGC Pharma Inc 1326205 |
| Balance Sheet |
|
Current Assets
|
$1,264,000.00 |
|
Assets
|
$9,496,000.00 |
|
Current Liabilities
|
$3,215,000.00 |
|
Liabilities
|
$3,364,000.00 |
|
Equity
|
$6,132,000.00 |
|
Shares Out
|
102417178.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,573,000.00 |
|
Investing Cash Flow
|
$-424,000.00 |
| Market Analysis |
Market Cap
|
$28,676,809.84 |
|
Price
|
$0.28 |
|
BVPS
|
0.06 |
|
PB
|
4.67 |
|
EPS
|
-0.03 |
|
PS
|
27.05 |
|
FCF
|
$-2,579,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:57 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:47 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view IGC documents filed with the SEC.
IGC Filings
Clear
